- Home
- SSRM vs KYMR Comparison
SSRM vs KYMR Comparison
Compare SSRM & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSRM | KYMR |
|---|---|---|
| Founded | 1946 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.7B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SSRM | KYMR |
|---|---|---|
| Price | $21.91 | $85.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 23 |
| Target Price | $21.89 | ★ $101.43 |
| AVG Volume (30 Days) | ★ 2.2M | 1.4M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $1,431,099,000.00 | $43,735,000.00 |
| Revenue This Year | $58.80 | $20.81 |
| Revenue Next Year | $45.35 | N/A |
| P/E Ratio | $21.16 | ★ N/A |
| Revenue Growth | ★ 30.30 | N/A |
| 52 Week Low | $6.79 | $19.45 |
| 52 Week High | $25.98 | $103.00 |
Technical Indicators
Market Signals| Indicator | SSRM | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 65.77 |
| Support Level | $20.81 | $86.23 |
| Resistance Level | $23.15 | $93.82 |
| Average True Range (ATR) | 0.93 | 4.75 |
| MACD | 0.09 | 1.86 |
| Stochastic Oscillator | 41.54 | 55.41 |
Price Performance
Historical ComparisonAbout SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.